Diabetic heart disease: Impaired stem cells in heart ups mortality but novel treatment brings hope
Diabetic heart disease is common among patients of type 2 diabetes. But hopes in the form of a new treatment may soon be here. Read on to know more. | | Updated: March 13, 2021 11:19 am
Apart from identifying the reasons for poor stem cells function in a patient with diabetes, the novel therapy of using microRNA could change the treatment method for heart disease in diabetic individuals.
Type 2 diabetes is a major global health problem and millions of people across the world fall prey to this condition annually. This disease brings with it many other health complications including a higher risk of serious conditions like kidney and heart diseases. These add-on health complications, including diabetic heart disease, add to the mortality rate of people who have diabetes. Now researchers from the University of Otago have discovered one of the reasons why more than 50 per cent
Đái Tháo Đường: Biến Chứng Là Do Lơ Là Kiểm Soát Đường Huyết
tin247.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tin247.com Daily Mail and Mail on Sunday newspapers.
Đái tháo đường: Biến chứng là do lơ là kiểm soát đường huyết
dantri.com.vn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dantri.com.vn Daily Mail and Mail on Sunday newspapers.
email article
Developing type 1 diabetes (T1D) in childhood was significantly associated with a shorter opportunity for childbearing, a new study showed.
Women diagnosed with T1D in childhood had an average 2.5 fewer reproductive years compared with their nondiabetic counterparts (95% CI -3.6 to -1.5,
P 0.0001), reported Tina Costacou, PhD, of the University of Pittsburgh, and colleagues.
Shortening of the reproductive window occurred on both sides, the researchers wrote in
Menopause, the journal of the North American Menopause Society (NAMS).
Specifically, women with T1D were an average 0.5 years older at the time of menarche and tended to be younger at the time of natural menopause onset, by 2 years on average. This was following adjustment for age, race, BMI, smoking status, hypertension, HDL cholesterol levels, history of oral contraceptives, and number of pregnancies.